The pathogenic fungus Candidozyma Auris is spreading rapidly in European hospitalsthis stems from the report published on Thursday by the European Center for Prevention and Control of Diseases (ECDC), writes TASR. This yeast infection (also known as Candida Auris, note TASR), which first recorded in Japan in 2009, According to the ECDC, he presents a serious threat to patients. The number of cases increases, The epidemics expand. Several countries report local spread. The findings point to the importance of early detection and transmission control to prevent the rapid spread of the fungus.
The infection usually spreads in medical facilities. Is often drug resistant and can cause serious problems in severely ill patients. Its ability to experience on various surfaces and medical equipment and spread among patients makes it difficult to manage its spread.
Between 2013 and 2023 of the European Economic Area (EEC), which includes all 27 EU Member States, Iceland, Liechtenstein and Norway, reported more than 4000 cases. Only in the very year of 2023 there was a significant increase in 1346 cases reported by 18 countries. Five countries – Spain, Greece, Italy, Romania and Germany – have experienced most cases over the last ten years. ECDC states in its report that these numbers are only “the tip of the iceberg“Because many countries do not systematically record cases of infection with this mold.
However, according to experts in Germany there is no reason for concernwrites DPA. Oliver Kurzai, Director of the Institute of Hygiene and Microbiology at the University of Julius and Maximilian in Würzburg, explained at a press conference organized by the Center for Scientific Media on Wednesday that Hospitalized patients in Germany may not worry despite the increasing number of cases. According to him, this fungus is rare in Germany.
“From an epidemiological point of view, this is concerned about us, but For individual patients, the likelihood of contact with her is low”Kurzai said. Germany reported in total during the period under review 120 cases, of which 77 occurred in 2023. Compared to the other countries mentioned above This is a significantly lower number. However, this data may be undervalued according to the ECDC The actual range of the problem is probably much larger.
